Skip to content

NEURO - Prognostication Using Late Somatosensory Evoked - Potentials

NEURO - Prognostication Using Late Somatosensory Evoked - Potentials

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07506928
Acronym
NEURO-PULSE
Enrollment
50
Registered
2026-04-02
Start date
2026-06-30
Completion date
2028-06-30
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comatose, Critical Care, Prognosis

Keywords

Prognostication, Somatosensory evoked - potentials, Neurocritical care, Machine learning, Continuous EEG

Brief summary

The main aim of this study is to develop a new technique for the passive diagnosis of cognitive-motor dissociation, with the detection of motor intention in a comatose patient by analysing the EEG signal and in particular the ERD/ERS amplitudes in the motor cortex after stimulation of the median nerve.

Detailed description

The utilisation of brain-computer interfaces (BCI) employing median nerve stimulation has the potential to yield novel insights into the enhancement of neuroprognostication. The application of painless, low-intensity electrical stimulation to the median nerve has been shown to activate the somatosensory cortex and the motor cortex via cutaneous and proprioceptive afferents. The activation in question has been shown to induce specific modulations of the electroencephalogram (EEG) signal, characterised by event-related desynchronisation (ERD) during stimulation, followed by resynchronisation (ERS) afterwards. The application of this stimulation during a motor task - that is to say, voluntary movement or motor imagery - results in a marked attenuation of post-stimulation ERS, or even its complete absence. The intention to move a hand, when coinciding with median nerve stimulation, amplifies the cortical ERD/ERS signatures, and is made more easily detectable by machine learning algorithms. The main aim of this study is to develop a new technique for the passive diagnosis of cognitive-motor dissociation, with the detection of motor intention in a comatose patient by analysing the EEG signal and in particular the ERD/ERS amplitudes in the motor cortex after stimulation of the median nerve.

Interventions

OTHEREEGs

All patients included in the study will receive electroencephalograms (EEGs) of post-stimulation event-related desynchronisation (ERD)/event-related synchronisation (ERS) amplitudes of the median nerve on two occasions per week. These recordings will be made twice a day, once in the morning and once in the afternoon/evening, in order to take account of the patients' inherent nycthemeral rhythm. A recording of 12 EEG electrodes from the scalp will be made during painless stimulation of the median nerve. The intensity of this stimulation will range from 3 to 14 mA, with a duration of 0.1 ms and a frequency of 5 Hz. This will result in a multiplication of the recording periods during and after stimulation. A final period of approximately 15 minutes of recording will be carried out with headphones on the patient, using simple, pre-recorded, standardized commands. These recordings will be continued for a period of three weeks following their inclusion.

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER
Inria, the French National Institute for computer science and applied mathematics
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This prospective interventional study involves the use of passive somaesthetic stimulation, which is defined as painless electrical stimulation of the median nerve, in conjunction with electroencephalogram (EEG) recordings. The study is being conducted in a single centre, specifically the neuro-resuscitation department of the Pellegrin Hospital in Bordeaux

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be aged 18 years or over; * Patients must be admitted to the intensive care unit with a cerebrovascular pathology; * Patients must be in a comatose state with a Glasgow score strictly less than 8, 24 hours after stopping sedation. * Representative of the patient informed of the research and not objecting to it, information and collection of the participant's non-objection if recovery of the ability to understand the content of the information note, * The patient is a recipient of or affiliated with a social security scheme.

Exclusion criteria

* Bilateral lesions of the motor cortex or cortico-spinal fasciculus, * Cutaneous infection of the scalp or any other lesion making surface electroencephalography impossible, * Patient whose short-term survival (48 - 72 hours) seems compromised, * Severe peripheral neuromyopathy, * Severe Acute Respiratory Distress Syndrome at the time of screening, * Hearing-impaired patients with hearing aids, * Pregnant or breastfeeding woman, * Patient under legal protection (persons deprived of their liberty or under guardianship).

Design outcomes

Primary

MeasureTime frameDescription
Alterations in the electroencephalogram3 weeks after inclusionThe alterations in the electroencephalogram (EEG) signal in the event-related desynchronisation/event-related synchronisation cortical signature following median nerve stimulation will be analysed and correlated with the emergence of clinical motor intention. The detection of cognitive-motor dissociation will rely on classification algorithms that detect the presence of motor activity in EEG signals following median nerve stimulation (MNS). The EEG signals recorded immediately after MNS will be represented as one or more covariance matrices, and several classifiers, including Riemannian classifiers, will then be trained on these matrices to classify a state of rest or motor activity in the EEG.
CRS-R score3 weeks after inclusionProgression of the Clinical Rating Scale-Revised (CRS-R) score: Standardized clinical scale assessing level of consciousness across six subdomains: auditory, visual, motor, oromotor/verbal, communication, and arousal. Total score: 0 to 23 Interpretation: Lower scores indicate absence or very low levels of consciousness (coma or vegetative state/unresponsive wakefulness syndrome). Intermediate scores indicate minimal but definite behavioral evidence of consciousness (minimally conscious state). Higher scores indicate more complex behaviors consistent with a higher level of consciousness (emergence from the minimally conscious state).
Glasgow score3 weeks after inclusionGlasgow Coma Scale (GCS) Standardized clinical scale assessing level of consciousness based on three components: eye opening, verbal response, and motor response. Total score: 3 to 15 Interpretation: Lower scores indicate severe impairment of consciousness (coma or deep unconsciousness). Intermediate scores indicate moderate impairment of consciousness. Higher scores indicate mild or no impairment of consciousness.

Secondary

MeasureTime frameDescription
GOS-E6 months after inclusionThe functional neurological prognosis in the period subsequent to the event will be evaluated by the Glasgow Outcome Scale-Extended (GOS-E) Standardized clinical scale assessing functional outcome and disability following brain injury, based on overall level of independence and social functioning. Total score: 1 to 8 Interpretation: Lower scores indicate severe disability or death. Intermediate scores indicate moderate disability with some level of independence. Higher scores indicate good recovery with return to independent functioning.
SF366 months after inclusionThe functional neurological prognosis in the period subsequent to the event will be evaluated by the Short Form-36 Health Survey (SF-36) Standardized patient-reported outcome measure assessing health-related quality of life across eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perception, vitality, social functioning, role limitations due to emotional problems, and mental health. Score range: 0 to 100 for each domain (and summary scores) Interpretation: Lower scores indicate poorer health-related quality of life. Higher scores indicate better health-related quality of life.

Countries

France

Contacts

CONTACTGeoffroy MOUCHEBOEUF, MD
geoffroy.moucheboeuf@chu-bordeaux.fr05 57 82 19 95
CONTACTGrégoire CANE, MD
gregoire.cane@chu-bordeaux.fr
PRINCIPAL_INVESTIGATORGeoffroy MOUCHEBOEUF, MD

University Hospital, Bordeaux

STUDY_DIRECTORGrégoire CANE, MD

University Hospital, Bordeaux

STUDY_CHAIRFabien LOTTE

Institut National de Recherche en Informatique et en Automatique

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026